Search Results - "Hedt, Amos"
-
1
High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting
Published in PloS one (27-08-2015)“…Abdurins are a novel antibody-like scaffold derived from the engineering of a single isolated CH2 domain of human IgG. Previous studies established the…”
Get full text
Journal Article -
2
64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Published in The Journal of nuclear medicine (1978) (01-06-2019)“…Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrine neoplasia and determining the suitability of patients for…”
Get full text
Journal Article -
3
Radiological properties of Next Generation Theranostics (Cu-64/Cu-67)
Published in The Journal of nuclear medicine (1978) (01-05-2017)“…Objectives: To examine the radiological properties of Next Generation Theranostics: Methods: Next generation theranostics can potentially offer improvements on…”
Get full text
Journal Article -
4
A Novel Theranostic Trial Design Using 64Cu/67Cu with Fully 3D Pre-Treatment Dosimetry
Published in The Journal of nuclear medicine (1978) (01-05-2019)“…Aim: The main purpose of this trial is to study the first-in-man biodistribution and radiation dosimetry estimates for the beta- & gamma-emitter Copper-67…”
Get full text
Journal Article -
5
Implementation of a whole body SPECT-CT imaging protocol for post-treatment dosimetry of 67Cu-SARTATE
Published in The Journal of nuclear medicine (1978) (01-05-2019)“…Aim: To implement a fully 3D imaging protocol, based on whole body SPECT-CT without the use of planar imaging, for patient specific whole body dosimetry…”
Get full text
Journal Article -
6
Development of 67Cu quantitative SPECT for clinical dosimetry
Published in The Journal of nuclear medicine (1978) (01-05-2018)“…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
Get full text
Journal Article -
7
Development of ^sup 67^Cu quantitative SPECT for clinical dosimetry
Published in The Journal of nuclear medicine (1978) (01-05-2018)“…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
Get full text
Journal Article -
8
Harnessing 64 Cu/ 67 Cu for a theranostic approach to pretargeted radioimmunotherapy
Published in Proceedings of the National Academy of Sciences - PNAS (10-11-2020)“…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
Get full text
Journal Article -
9
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy
Published in Proceedings of the National Academy of Sciences - PNAS (10-11-2020)“…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
Get full text
Journal Article -
10
64 Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Published in Journal of Nuclear Medicine (01-06-2019)“…Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrine neoplasia and determining the suitability of patients for…”
Get full text
Journal Article